F TD, the second most common form of presenile dementia, overlaps clinically, pathologically and genetically with the motor neuron disease ALS 1, 2 . Many genetic mutations cause both ALS and FTD; the most prevalent is a GGGGCC (G 4 C 2 ) repeat expansion in the non-coding region of C9ORF72 (refs. 3,4 ). Studies in cellular and animal models have uncovered several downstream molecular pathways that are dysregulated in C9ORF72-related ALS/ FTD, including the autophagy, nucleocytoplasmic transport, premessenger RNA splicing, stress granule dynamics and DNA damage repair pathways 5 . However, it is unclear which molecular events initiate disease.
F TD, the second most common form of presenile dementia, overlaps clinically, pathologically and genetically with the motor neuron disease ALS 1, 2 . Many genetic mutations cause both ALS and FTD; the most prevalent is a GGGGCC (G 4 C 2 ) repeat expansion in the non-coding region of C9ORF72 (refs. 3, 4 ). Studies in cellular and animal models have uncovered several downstream molecular pathways that are dysregulated in C9ORF72-related ALS/ FTD, including the autophagy, nucleocytoplasmic transport, premessenger RNA splicing, stress granule dynamics and DNA damage repair pathways 5 . However, it is unclear which molecular events initiate disease.
One of the major unusual features of C9ORF72-related ALS/ FTD is the accumulation of proteins containing dipeptide repeats (DPRs) and the formation of DPR aggregates in patient neurons, mostly in the cytoplasm [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . These endogenous abnormal proteins, such as poly(GA), poly(GR), poly(GP), poly(PR) and poly(PA), can be synthesized from either sense or antisense transcripts containing expanded hexanucleotide repeats, potentially through different translation mechanisms in human patient cells, including repeat-associated non-AUG (RAN) translation 16, 17 . Multiple lines of evidence suggest that arginine-containing DPR proteins are highly toxic when ectopically expressed in experimental systems. In Drosophila, for instance, poly(GR) and poly(PR) expression induces the death of neuronal and non-neuronal cells [18] [19] [20] . In mammalian cells, poly(GR) and poly(PR) expression causes nucleolar stress [19] [20] [21] [22] , increases DNA damage 23, 24 and blocks the nuclear pore through interactions with proteins containing FG domains 25 . However, it is not known whether low-level expression of arginine-containing DPR proteins in mice induces ALS/FTDrelevant phenotypes and which cellular defect occurs first during disease onset.
The exact pathogenic roles of individual DPR proteins in patient brains are unclear, in part because different DPR proteins are present in both aggregated and diffusible forms [10] [11] [12] [13] . Two recent studies showed that poly(GR) is associated with neurodegeneration in the brains of patients with C9ORF72-related ALS/FTD 14, 15 , suggesting a central role for poly(GR) in disease pathogenesis. To help understand how poly(GR) initiates neurodegenerative processes in vivo, we established a mouse model in which (GR) 80 is expressed in the brain at a substantially lower level than in C9ORF72-related ALS/ FTD brain tissues, under the control of an inducible promoter. Using this model, we discovered that mitochondrial defects are a major driver of disease initiation in C9ORF72-related ALS/FTD.
Results
Establishment of a mouse model of C9ORF72-ALS/FTD with inducible low level of poly(GR) expression. To determine whether low-level poly(GR) expression can cause ALS/FTD disease-associated phenotypes in mice, we took advantage of the tetracyclinecontrolled inducible expression system to express (GR) 80 postnatally in excitatory neurons of all layers of the cortex (Fig. 1a) . To this end, we used the same method and transgenic vector as we used before to express FTD3-associated mutant charged multivesicular body protein 2B (CHMP2B) protein at a level substantially lower than endogenous mouse Chmp2B (ref. 26 ). Eighty copies of GR are probably a disease-relevant size, because even a few dozen G 4 C 2 repeats can cause disease in humans and mice 27, 28 . We engineered a transgenic vector containing the tetracycline response element, an ATG codon and a sequence encoding the FLAG epitope tag followed by a (GGXCGX) 80 sequence encoding (GR) 80 (Fig. 1a) . Transgenic mice were generated, and three founder lines were crossed with calcium/calmodulin-dependent protein kinase II alpha-tetracycline
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transactivator (CamKII-tTA) mice for further expression analysis. At 2 months of age, the (GR) 80 mRNA expression levels in the cortex of CamKII-tTA; (GR) 80 mice were about 9 times higher in line 8 than in line 16, and 4 times higher in line 16 than in line 18 (Fig. 1b) . To avoid the overexpression problem often encountered with transgenic mouse models of neurodegenerative diseases, the intermediate expresser line 16 was used for all experiments.
At 2 months of age, cortical expression of (GR) 80 protein in line 16 CamKII-tTA; (GR) 80 mice was undetectable (Fig. 1c) , even though CamKII-tTA drives transgene expression postnatally. By 6 months of age, (GR) 80 was still undetectable with a fluorescein-conjugated secondary antibody; however, 3,3'-diaminobenzidine (DAB) staining after amplification of the signal with a biotinylated secondary antibody detected (GR) 80 expression in the soma and dendrites of a few neurons, mostly in the frontal cortex (Fig. 1c) . By 8 months of age, the number of (GR) 80 -positive neurons had increased (Fig. 1c) . Poly(GR) accumulated mostly in the frontal cortex; this finding was confirmed in 8-month old mice of high-expresser line 8 ( Supplementary Fig. 1a,b) .
The difficulty of detecting (GR) 80 expression in young mice of line 16 raises the possibility that it is expressed at a relatively low level. Therefore, we generated a polyclonal antibody specific to poly(GR) with no reactivity to poly(GA) and poly(GP) ( Supplementary  Fig. 1c ). Using this antibody, we established a sensitive enzymelinked immunosorbent assay (ELISA) that can detect poly(GR) in the range of a few nanograms per milligram (Fig. 1d ). This assay confirmed the age-dependent accumulation of poly(GR) in CamKII-tTA;(GR) 80 mice (Fig. 1e ). More importantly, the poly(GR) level in the frontal cortex of 3-7-month-old CamKII-tTA; (GR) 80 mice was only about 5-15% of that in postmortem frontal cortex tissues of patients with C9ORF72-related ALS/FTD (Fig. 1f) . As in C9ORF72 induced pluripotent stem cell (iPSC)-derived neurons 23 and in CamKII-tTA; (GR) 80 mice (Fig. 1e) , it is highly likely that poly(GR) also accumulates in an age-dependent manner in patient brains. Nonetheless, the poly(GR) level in mice is regarded as low and well within the disease-relevant range.
Similar to endogenous poly(GR) in patient brains [12] [13] [14] , poly(GR) in CamKII-tTA;(GR) 80 mice is mostly found in the cytoplasm of neurons. Detailed analysis revealed that poly(GR)-expressing neurons can be grouped into four classes: neurons with poly(GR) diffusely distributed in the cytosol (type A), neurons with cytosolic and nuclear diffuse form of poly(GR) (type B), neurons with cytosolic aggregated form of poly(GR) (type C) and neurons with cytosolic and nuclear aggregates of poly(GR) (type D) (Fig. 1g) . The nuclear localization of some poly(GR) aggregates in type B and type D neurons was further confirmed by analysis of confocal z-stack section ( Supplementary Fig. 1d ). Interestingly, in about 95% of neurons, poly(GR) did not form large aggregates (Fig. 1h) , raising the possibility that diffusible poly(GR) can be neurotoxic in vivo.
CamKII;(GR) 80 mice show age-dependent ALS/FTD-like social behavioral deficits and impaired synaptic function. C9ORF72-related FTD often manifests as the behavioral variant FTD 1 . To determine whether low-level poly(GR) expression in excitatory neurons of CamKII;(GR) 80 mice causes ALS/FTD-like social behavioral deficits, we used the three-chamber social interaction test 29 . The test mouse is placed in the middle chamber and allowed to explore freely for 10 min (habituation). Then, a stranger mouse is placed in a wire cage in the left chamber and a novel wooden object is placed in the right chamber (Fig. 2a) . Both CamKII mice and CamKII;(GR) 80 mice of different ages spent equally greater amounts of time in the left chamber than in the two other chambers, and, in the left chamber, both CamKII mice and CamKII;(GR) 80 mice spent equal amounts of time in the left chamber (Fig. 2b,c and Supplementary  Fig. 2a ), suggesting a normal ability to recognize a conspecific subject. However, 6-and 9-month-old, but not 3-month-old, CamKII;(GR) 80 mice spent less time interacting with the stranger mouse in the left chamber, even though they stayed there as long as control mice (Fig. 2b,c and Supplementary Fig. 2a ), indicating an age-dependent deficit in social behavior, as seen in patients with FTD 1 . Similarly, 6-and 9-month-old, but not 3-month-old, CamKII;(GR) 80 mice exhibited an age-dependent increase in anxiety in the elevated plus maze test ( Fig. 2d and Supplementary Fig. 2b-d) . These behavioral deficits most probably do not reflect a general deterioration in health, since CamKII; (GR) 80 mice at these ages weighed the same as controls (Supplementary Fig. 3a) . Moreover, the total distance traveled, the average speed and the frequency of passing through the center chamber were indistinguishable between CamKII; (GR) 80 and CamKII mice at 3, 6 and 9 months of age in the open-field test ( Supplementary Fig. 3b-d) . In contrast, working memory of CamKII; (GR) 80 mice in the T-maze test remained intact ( Supplementary Fig. 4 ). These results indicate a specific deficit in social behavior, which is probably caused by synaptic defects in the neuronal circuit involving the prefrontal cortex, where poly(GR) accumulates. Indeed, at 6 months of age, CamKII;(GR) 80 mice had significantly reduced cortical expression of the postsynaptic scaffolding protein discs large MAGUK scaffold protein 4 (Dlg4), also known as PSD-95 (Fig. 2e) , suggesting a defect in synaptic structure or function.
To investigate the effects of poly(GR) on synaptic transmission in prefrontal cortex neurons in CamKII; (GR) 80 mice, we analyzed AMPA receptor-mediated miniature excitatory postsynaptic currents (mEPSCs) in layer V pyramidal neurons, the major cortical output relay that exerts top-down control of subcortical brain centers and behavior 30 . Whole-cell patch-clamp recordings were made from acute medial prefrontal cortex slices derived from 4.5-month-old CamKII; (GR) 80 and CamKII mice (Fig. 2f ). mEPSCs were recorded at -70 mV in the presence of tetrodotoxin (1 μM) and picrotoxin (100 μM) to block voltage-gated Na + currents and GABA A receptor-mediated inhibitory responses, respectively. The amplitude of mEPSCs did not differ in CamKII; (GR) 80 and CamKII mice (Fig. 2g) , suggesting that postsynaptic AMPA receptor activity is largely unaltered in the prefrontal cortex of mutant mice. In contrast, the frequency of mEPSCs was significantly reduced in CamKII;(GR) 80 mice (Fig. 2h) , indicating a loss of functional synapses, a decrease in the probability of presynaptic glutamate release or both. These findings show that poly(GR) impairs synaptic connection and efficacy in the prefrontal cortex in vivo.
CamKII;(GR) 80 mice show other ALS/FTD-related cellular phenotypes. In addition to behavioral and synaptic deficits, lowlevel poly(GR) expression alone can induce other ALS/FTDrelevant cellular phenotypes in vivo. At 6 months but not 3 months of age, neurons containing cleaved caspase 3 were very rare but more abundant in CamKII; (GR) 80 mice than in controls (only 20 cells or so per cortical section) (Fig. 3a,b) , and more abundant in the frontal cortex than in the parietal and occipital cortex of CamKII;(GR) 80 mice (Fig. 3c) , indicating a strong correlation between poly(GR) accumulation and neuronal cell death in this cortical region. Those caspase 3-positive neurons were mostly type C and type D poly(GR)-expressing neurons ( Supplementary  Fig. 5 ), indicating that aggregated poly(GR) is associated with dying neurons; however, the vast majority of neurons are probably functionally compromised by diffusible poly(GR), accounting for the behavioral defects. Accordingly, there was an age-dependent loss of neuronal cells, as shown by the quantification of RNA-binding protein fox-1 homolog 3 (Rbfox3, also known as NeuN)-positive neurons in the frontal cortex of 3-, 6-and 9-month-old CamKII;(GR) 80 mice (Fig. 3d ). These mice also had an age-dependent increase in microglia, as judged from the higher number of IbaI-positive microglia and the greater branching of their processes than in controls (Fig. 3e,f) . Some microglial cells seem to be activated, as they expressed the marker Clec7a and had round, IbaI-positive cell bodies (Fig. 3g) . Astrogliosis seemed to be elevated as well, as shown by increased glial fibrillary acidic protein (Gfap) expression ( Supplementary Fig. 6 ). However, Rangap1 mislocalization, TAR DNA binding protein 43 (TDP-43) aggregation and altered Sequestosome 1 (Sqstm1), also known as p62, levels were not found in the cortex of >6-month-old CamKII; (GR) 80 mice, suggesting that these molecular defects are not associated with the initiation of poly(GR)-induced disease phenotypes ( Supplementary Fig. 7 ).
Poly(GR) compromises mitochondrial morphology and function in CamKII;(GR) 80 mice. Previously, we reported that neurons derived from C9ORF72 iPSCs have an age-dependent increase in DNA damage and that ectopic expression of poly(GR) increases DNA damage in control iPSC-derived neurons 23 . Consistent with these findings, cortical neurons with elevated DNA damage were abundant in 6-month-old but not 3-month-old CamKII; (GR) 80 mice, as shown by immunostaining for histone H2AX (γH2AX), a marker of double-stranded DNA damage 31 (Fig. 3h,i ). All neurons with increased DNA damage expressed poly(GR) ( Supplementary  Fig. 8 ), suggesting a cell-autonomous effect of poly(GR) toxicity.
To study molecular defects that lead to increased DNA damage in CamKII; (GR) 80 mice, we examined the morphology and function of mitochondria, a major source of reactive oxygen species that damage DNA 31 . Strikingly, electron microscopy analysis revealed that disruption of the inner mitochondrial membrane and loss of cristae were increased in the prefrontal cortex of CamKII; (GR) 80 mice at 3 months of age (Fig. 4a,b) . The defect was more pronounced in 6-month-old CamKII;(GR) 80 mice, indicating an age-dependent accumulation of mitochondrial damage. Because some cellular defects and behavioral deficits were not obvious in 3-month-old CamKII; (GR) 80 mice, our finding raises the interesting possibility that mitochondrial defects are an early pathogenic event in this mouse model of C9ORF72-ALS/FTD. We performed additional assays to measure mitochondrial length of primary cortical neurons isolated from CamKII and CamKII; (GR) 80 mice at 14 d in vitro (Fig. 4c) . Mitochondria in CamKII;(GR) 80 neurons seemed to be shorter (Fig. 4c) ; indeed, detailed quantification 80 (17) CamKII ( indicated that mitochondria less than 1.0-μm long were more numerous in CamKII; (GR) 80 neurons than in CamKII neurons (Fig. 4d) . Moreover, the average mitochondrial length in neurites was shorter in many CamKII;(GR) 80 neurons than in CamKII neurons (Fig. 4e) .
Moreover, mitochondria in cultured CamKII; (GR) 80 neurons were less motile than those in control neurons ( Supplementary Fig. 9 ). Interestingly, in accordance with mitochondrial fragmentation, the level of the mitochondrial fission protein dynamin 1-like (Dnm1l), also known as DRP1, was increased and that of the mitochondrial fusion protein optic atrophy 1 (OPA1) was decreased in the cortex of 9-month-old CamKII;(GR) 80 mice ( Supplementary Fig. 10 ), further indicating a defect in mitochondrial dynamics. Next, we sought to test whether these morphology changes would have an effect on the main mitochondrial function, the production of ATP through oxidative phosphorylation mediated by respiratory chain complexes. We found decreased activities of mitochondrial complexes I and V in the frontal cortex of 6-month-old mice (Fig. 4f) .
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To investigate how poly(GR) affects mitochondrial function, we first analyzed the subcellular location of poly(GR) in mouse brain neurons at high resolution. In type A poly(GR)-expressing neurons of 9-month-old CamKII;(GR) 80 mice, poly(GR) was diffusely expressed in the soma and proximal dendrites, including inside mitochondria (Fig. 4g) , although the intensity of the poly(GR) signal was generally weaker inside than outside of mitochondria (Fig. 4g) . The specificity of the poly(GR) signal was demonstrated by its absence in mitochondria in cells that did not express poly(GR) (Fig. 4g) . To further confirm the presence of poly(GR) in mitochondria, we examined type C neurons of 9-month-old CamKII;(GR) 80 mice with a high level of poly(GR) expression (line 8), where poly(GR) formed droplets or small aggregates in the soma and proximal dendrites ( Supplementary  Fig. 11 ). Most poly(GR) aggregates did not overlap with mitochondria; however, mitochondria often appeared to be in close contact with poly(GR) droplets and diffusible poly(GR) was clearly present in mitochondria ( Supplementary Fig. 11a′, b′) . The poly(GR) signal was specific, as no signal was observed in mitochondria that did not express poly(GR) (Supplementary Fig. 11c′ ). This notion is further supported by immuno-electron microscopy analysis of HEK293 cells expressing green fluorescent protein (GFP)-(GR) 80 . Judging from the number of gold particles coated with poly(GR)-specific antibody, poly(GR) was indeed present in mitochondria (Fig. 4h,i) , in contrast to a recent report that poly(GR) is not localized in mitochondria 32 . Thus, nonaggregated or diffusible forms of poly(GR) may directly affect mitochondrial morphology and function.
Poly(GR) interacts with and decreases expression of Atp5a1 in
CamKII;(GR) 80 mice. To investigate the molecular mechanism of poly(GR)-induced mitochondrial dysfunction, we did coimmunoprecipitation experiments to pull down poly(GR) in transfected HEK293 cells and then used an OXPHOS antibody cocktail to identify mitochondrial respiratory chain complex proteins that may interact with poly(GR). We found that poly(GR) preferentially binds to ATP synthase F1 subunit alpha (ATP5FA1), also known as ATP5A1, a subunit of mitochondrial respiratory chain complex V (Fig. 5a ). This interaction was confirmed by reverse immunoprecipitation experiments in which an ATP5A1 antibody was used to pull down poly(GR) (Supplementary Fig. 12a ). To determine how the binding between poly(GR) and ATP5A1 affects mitochondrial function, we found that the endogenous expression level of Atp5a1 was decreased in poly(GR)-expressing primary cortical neurons cultured from CamKII;(GR) 80 mice, as shown by immunostaining and western blot analyses (Fig. 5b-d) , as well as in poly(GR)-expressing neurons in the CamKII;(GR) 80 mouse brain ( Supplementary  Fig. 12b ). More importantly, the Atp5a1 protein level was also reduced in the cortex of 6-month-old CamKII;(GR) 80 mice (Fig. 5e ) and in the frontal cortex of 4 C9ORF72-related ALS/FTD patients compared with 3 control brains (Fig. 5f ). This decrease is not due to transcriptional regulation since the Atp5a1 mRNA level was not affected in CamKII;(GR) 80 mice at 6 months of age ( Supplementary  Fig. 12c ). Moreover, protein levels of some other mitochondrial proteins such as NADH:ubiquinone oxidoreductase subunit B8 (Ndufb8); succinate dehydrogenase complex iron sulfur subunit B (Sdhb); ubiquinol cytochrome c reductase core protein 2 (Uqcrc2); Hspd1 heat shock protein 1 (Hspd1, also known as HSP60); and ATP synthase, H + -transporting, mitochondrial F0 complex, subunit D (Atp5h), were not affected in the cortex of CamKII;(GR) 80 mice or C9ORF72-related ALS/FTD brains ( Fig. 5g and Supplementary  Fig. 13 ). Together, these results suggest that poly(GR) specifically decreases Atp5a1 levels in CamKII;(GR) 80 mice and that this interaction may be partly responsible for compromised mitochondrial morphology and function.
Poly(GR) increases ATP5A1 ubiquitination and degradation via the proteasome pathway and ectopic expression of Atp5a1 rescues neurodegeneration of CamKII;(GR) 80 neurons. To understand the molecular mechanism by which poly(GR) decreases the Atp5a1 level in CamKII; (GR) 80 mice, we did a series of experiments. First, we found that ubiquitination was increased in the cortex of CamKII;(GR) 80 mice at 6 months of age (Fig. 6a,b) , suggesting that some proteins have increased ubiquitination and/or some ubiquitinated proteins accumulate. Next, to examine the ubiquitination status of ATP5Α1, we immunoprecipitated endogenous ATP5Α1 and then used anti-ubiquitin and anti-ATP5Α1 antibodies for western blot analysis, and, under this experimental condition, ATP5Α1 with higher molecular weight was greatly enriched in the immunoprecipitated fraction, which is probably due to increased accessibility of ATP5Α1 epitopes to this antibody on these isoforms (Fig. 6c) . We found that ubiquitination of ATP5Α1 was increased in (GR) 80 transfected HEK293 cells compared with GFP-transfected cells (Fig. 6c,d) . Finally, to examine whether the increased ubiquitination of ATP5Α1 could in part explain its reduced levels in the presence of (GR) 80 , we treated GFP-or (GR) 80 -transfected HEK293 cells with cycloheximide (CHX) for 30 h to block protein synthesis and then examined degradation of ATP5A1. In GFP-transfected cells, the ATP5A1 level was not significantly affected by treatment with CHX or the proteasome inhibitor MG132 with this time window, suggesting a relatively long half-life (Fig. 6e,f) consistent with an earlier study on ATP5A1 protein stability 33 , although some other mitochondrial proteins are more susceptible to degradation through the ubiquitin-proteasome pathway 33, 34 . Interestingly, in cells expressing (GR) 80 and treated with CHX, ATP5A1 degraded faster, which was probably through the proteasome pathway because concurrent treatment with MG132 prevented its degradation (Fig. 6e,f) . Thus, poly(GR) increases ubiquitination of ATP5Α1 and its degradation through the proteasome pathway.
To determine whether an increase in ectopic Atp5a1 protects from poly(GR) toxicity, we overexpressed Atp5a1 using lentiviral transduction in primary cortical neurons isolated from CamKII;(GR) 80 mice. Atp5a1 overexpression decreased mitochondrial fragmentation in poly(GR)-expressing cortical neurons and restored ATP levels (Fig. 6g,h) . Moreover, Atp5a1 expression reduced the number of cleaved caspase 3-positive and pyknotic cells in poly(GR)-expressing primary cortical neurons (Fig. 6i,j) . These findings suggest that the direct interaction between poly(GR) and Atp5a1 results in its degradation via the ubiquitin-proteasome pathway and that restoring levels of Atp5a1 attenuates poly(GR) toxicity, resulting in increased ATP levels and neuronal survival.
Reducing poly(GR) production in adult mice rescues poly(GR)-induced neurodegeneration.
Next, we determined whether reducing the poly(GR) level alters the behavioral and cellular phenotypes in CamKII;(GR) 80 mice. Feeding mice with chow containing doxycycline beginning at 1 month of age to shut down expression of (GR) 80 prevented social behavioral deficits and reduced anxiety level at 6 months of age ( Supplementary Fig. 14) . To further test whether disease phenotypes can be at least partially reversed after disease onset, we turned off (GR) 80 expression in CamKII; (GR) 80 mice beginning at 7 months of age (Fig. 7a) , when disease-relevant behavioral and cellular phenotypes are already present. After 2 months of doxycycline treatment, the (GR) 80 level in the cortex greatly reduced in the 9-month-old mice (Fig. 7b) . As anticipated, the number of cleaved caspase 3-positive neurons in the cortex, especially the frontal cortex, was further elevated in 9-month-old (Fig. 7d) than 6-month-old (Fig. 3b) CamKII;(GR) 80 mice. Similarly, some other disease phenotypes such as DNA damage (Fig. 7e versus Fig. 3i ) and microgliosis ( Supplementary Fig. 15b versus Fig. 3f ) were also worsened in an age-dependent manner. Remarkably, these phenotypes were reduced in CamKII;(GR) 80 mice fed doxycycline for 2 months (Fig. 7c-e and Supplementary  Fig. 15a,b) . Also reversed were the increased levels of astrogliosis induced by poly(GR) in vivo ( Supplementary Fig. 15c,d) . Finally, the decrease in Atp5a1 level in the cortex of CamKII;(GR) 80 mice was partially reversed after the poly(GR) expression level was greatly reduced (Fig. 7f) . Thus, therapeutic strategies to lower poly(GR) levels can reverse disease phenotypes even after disease onset.
Discussion
In this study, we established a mouse model of C9ORF72-related ALS/FTD in which poly(GR) is expressed in the brain in a spatially and temporally controlled manner. We found that the poly(GR) level in the frontal cortex is about 85-95% lower in these mice at 3-7 months of age than in patients with C9ORF72-related ALS/FTD and that poly(GR) accumulates in the soma and dendrites of neurons in an age-dependent manner. Poly(GR) expression induced ALS/FTD-associated synaptic dysfunction and social behavioral deficits as well as neuronal cell loss, microgliosis and DNA damage. The increased DNA damage is probably a consequence of compromised mitochondrial morphology and function, which may result in increased oxidative stress that in turn causes DNA damage such as in C9ORF72 iPSC-derived motor neurons 23 . More importantly, poly(GR) preferentially bound to Atp5a1, a subunit of mitochondrial complex V, whose expression in the frontal cortex of CamKII;(GR) 80 mice and C9ORF72-related ALS/FTD brains was decreased probably in part through enhanced degradation via the ubiquitin-proteasome pathway-a molecular mechanism for poly(GR) toxicity. Moreover, several disease-relevant cellular phenotypes were reversed by ectopic expression of Atp5a1 in cultured neurons or by reducing the poly(GR) level in adult mice. Thus, it may be possible to develop therapies to decrease poly(GR) level and halt progression of C9ORF72-related ALS/FTD even after the onset of disease.
A key molecular event downstream of C9ORF72 repeat expansion is the production of DPR proteins, which are mostly localized in the cytoplasm [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The composition of DPR proteins in C9ORF72-related ALS/FTD neurons may be much more complex than initially thought and may depend on which translation mechanisms are in play 17 . Thus, mouse models of individual DPR protein toxicity 
are highly informative. Studies in patient brain tissues indicate that only poly(GR) is significantly more abundant in clinically related brain areas than in unrelated areas 14, 15 , suggesting that poly(GR) has a central role in disease pathogenesis. A major feature of our mouse model is that poly(GR) is expressed at a substantially lower level than in C9ORF72-related ALS/FTD brain tissues. Thus, a relatively low level of diffusible poly(GR) without aggregate formation can initiate disease in vivo.
Synaptic dysfunction in the prefrontal cortex probably underlies the social behavioral deficits in our mouse model, as this brain region is critically important for social cognition 30 . Interestingly, poly(GR) accumulated preferentially in the soma and dendrites of frontal cortex neurons, especially those in deep layers (Fig. 1) . This accumulation may result from a compromised degradation and might help explain the selective vulnerability of these neurons in patients with FTD. The observed synaptic dysfunction in CamKII; (GR) 80 mice can be caused at least in part by mitochondrial dysfunction as in other experimental systems [35] [36] [37] . Remarkably, morphological defects in mitochondria were present in CamKII; (GR) 80 mice at 3 months of age, before social behavioral and other cellular defects become apparent, suggesting that mitochondrial dysfunction is an early pathogenic event. Other cellular phenotypes, such as increased proliferation of microglia, could result from synaptic loss caused by cell-autonomous toxicity of poly(GR) in neurons, as microglia have a key role in the formation and maintenance of functional synapses 38 . Interestingly, at 6 months of age, when poly(GR)-induced disease phenotypes are present in CamKII; (GR) 80 mice, TDP-43 pathology seems to be absent ( Supplementary Fig. 7 ). Thus, poly(GR) itself may initiate disease, and the TDP-43 pathology in autopsy tissues of patients may be a late event in disease progression. Indeed, a case of C9ORF72-related FTD with RNA foci and DPR protein accumulation but without TDP-43 aggregation 13 y before autopsy has been reported 13 , and overexpression of poly(GA) also induces neurodegeneration in mice without obvious TDP-43 mislocalization and inclusion formation 39, 40 . At the mechanistic level, one important insight comes from the finding that poly(GR) preferentially binds to ATP5A1, a stable protein often used as a marker for mitochondrial complex V. Our immunostaining and immuno-electron microscopy analyses revealed that poly(GR) is present within mitochondria. Poly(GR) increased the ubiquitylation of ATP5Α1 and its degradation via the ubiquitinproteasome pathway. Indeed, expression of Atp5a1, but not some other mitochondrial proteins, was reduced in CamKII; (GR) 80 mice and in brain tissues of patients with C9ORF72-related ALS/FTD. It will be interesting to determine at the molecular level how a low level of poly(GR) increases Atp5a1 ubiquitination, and what other mechanisms contribute to selective reduction in the Atp5a1 protein level in CamKII;(GR) 80 mice. The biochemical interaction between poly(GR) and Atp5a1 seems to be a key pathogenic mechanism during disease initiation, since ectopic expression of Atp5a1 in primary neurons isolated from CamKII;(GR) 80 mice rescued poly(GR)-induced mitochondrial defects and neuronal cell death (Fig. 6) .
Finally, our finding that some aspects of poly(GR)-induced toxicity can be reversed even after disease onset is encouraging because it suggests that diffusible poly(GR) induces functional deficits long before neuronal cell death. Thus, therapeutic approaches to lower the poly(GR) level may be beneficial for C9ORF72-related ALS/ FTD even after the onset of clinical symptoms. Our poly(GR) mouse model will be useful to test these therapeutic approaches and to examine the contribution of genetic modifiers of poly(GR) toxicity, identified in other disease models.
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Methods
Mice and genotyping. All procedures involving mice were approved by The University of Massachusetts Medical School Institutional Animal Care and Use Committee. A DNA sequence encoding the Flag tag followed by 80 copies of the dipeptide GR (sequence (GGXCGX) 80 , FLAG-(GR) 80 ) was cloned into the pTRETight-BI-ZsGreen1 mammalian expression vector (Clontech) with the restriction enzymes NotI and SalI. Before microinjection into mouse oocytes, the vector was linearized with BbsI, which cuts the vector twice in the region encoding ZsGreen1 and removes a 447-base pair fragment to prevent expression of the ZSGreen 1 gene. The F1 litters were analyzed by PCR for transgene insertion with the following set of primers: forward 5´-GATTACAAGGACGACGACGA-3′ and reverse 5′-GACAAGTTATCAACGTCCAC-3′. Six germline-transmitting founders were obtained and backcrossed to wild-type C57BL/6 mice to maintain hemizygous lines. To express the transgene in the forebrain, the (GR) 80 transgenic male mice were crossed with CamKII-tTA female mice (Jackson Laboratory, 007004). Equal or near equal numbers of male and female double-transgenic offspring were used in all experiments. Except unexpected accidental death, all animals and data points are used in the analyses. Mice were randomly assigned to the various experimental groups and selected for behavioral experiments. Immunohistochemistry. Mice were anesthetized and perfused through a transthoracic cardiac puncture with prechilled 0.9% saline and then 4% paraformaldehyde (PFA). The brains were dissected and postfixed in 4% PFA at 4 °C for 2 d. After fixation, the brains were washed in PBS, allowed to sink in 30% sucrose solution at 4 °C, cut into 40-μm sections with a cryostat and stored in 50% glycerol solution at -20 °C.
For immunofluorescence studies, the brain tissues were washed in PBS and incubated in 3% BSA with 0.2% Triton X-100 (blocking solution) for 30 min at room temperature. The tissues were then incubated with primary antibodies in PBS containing 3% BSA and 0.2% Triton X-100 overnight on a shaker at room temperature. The primary antibodies were for NeuN (ABN78 and MAB377, Millipore; 1:1,000), cleaved caspase 3 (9661S, Cell Signaling; 1:500; 347683, United States Biological Life Science; 1:200), IbaI (019-19741, Wako; 1:1,000), glial fibrillary acidic protein (GFAP) (Z0334, Dako; 1:1,000), γH2AX (AB10022, Millipore; 1:500), HSP60 (MAB1800, R&D Systems; 1:500), Atp5a1 (14748, Abcam; 1:500), CamKII (611293, BD Biosciences; 1:500), Ran GAP1 (SC-25630, Santa Cruz Biotechnology; 1:500), CLE7A (217331, Abcam; 1:500) and poly-GR (ABN1361, Millipore; 1:2,000). Each antibody had been validated by the manufacturers. The brain tissues were then incubated with secondary antibodies conjugated with Alexa 488 and 586 (Invitrogen), washed in PBS and mounted in CC mounting medium (C9368, Sigma).
For DAB staining, the brain tissues were washed in PBS and pretreated with methanol containing H 2 O 2 to eliminate endogenous peroxidase. The tissues were then washed in PBS and incubated first in blocking solution for 30 min at room temperature and then with the poly-GR (ABN1361, Millipore; 1:2,000) or TDP-43 (12892-1-AP, Proteintech; 1:1,000) primary antibodies overnight on a shaker at room temperature. The tissues were washed with PBS, incubated with biotinylated secondary antibody (Vector), treated with avidin-biotin complex/horseradish peroxidase reagent solution (PK-7100, Vector) for 30 min, developed with a DAB substrate kit (SK-4105, Vector), stained with hematoxylin solution and mounted in Permount solution (SP15-100, Fisher).
Behavioral tests. Mice were singly housed in home cages and kept under specificpathogen-free conditions in an animal facility with a 12-h light/12-h dark cycle (light off at 7:00). All behavioral tests were done on 3-, 6-and 9-month-old mice between 9:00 and 17:00. To avoid effects of stress, behavioral tests were done at 2-3-d intervals. Before testing, mice were placed in the operating room to habituate for 20-30 min. ) between each chamber. For habituation, mice were placed in the center chamber and allowed to explore all chambers freely. After 10 min, a stranger mouse (randomly selected from a group of mice of the same sex and age as the experimental mice) and a novel wooden object (of the size and weight of a mouse) were placed under wire cages in the flanking chambers. Social ability was evaluated with the EthoVision system by measuring how long the test mouse spent sniffing the stranger mouse and the wooden object and the total time spent in each chamber.
T-maze. The T-maze test apparatus has 3 arms (30 × 10 cm 2 ) and is elevated 30 cm above the ground. During the first 24 h, mice were fed with small pieces of chow (1 g). On the next day, each mouse was kept for 20 min in the testing room to calm down and was then forced to run from the start arm to the left arm where food was placed as reward, while the door to the right arm was blocked. After 10 s, the mouse was allowed to enter either the left or right arm. If the mouse chose the left arm where food was placed, the event was counted as a success. This test was repeated 10 times for each mouse; 9-10 mice of each genotype were tested.
Electrophysiology. CamKII and CamKII;(GR) 80 mice (4.5 months of age) were killed. Their brains were rapidly removed and placed in saturated (95% O 2 /5% CO 2 ) ice-cold artificial cerebrospinal fluid (ACSF) containing 126 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 25 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 and 11 mM d-glucose. Coronal slices (300 μm) containing the medial prefrontal cortex (1.54-2.8 mm anterior to the bregma) were cut with a Leica VT1200 vibratome. Slices were collected into a tissue incubator (Harvard Apparatus), incubated in ACSF for at least 1 h at room temperature (21-23 °C), transferred to a recording chamber and continuously perfused with oxygenated ACSF by a gravity-driven perfusion system. Recordings were made at 32 °C; temperature was maintained with a temperature controller (Warner Instruments).
Whole-cell voltage-clamp recordings of individual layer V pyramidal neurons in the anterior cingulated cortex, prelimbic cortex or both were done with an Axopatch 200B amplifier (Molecular Devices). Pyramidal neurons were identified morphologically by infrared differential interference contrast microscopy. Recording pipettes (4.5-5.5 MΩ) were filled with solution containing 142 mM Cs-gluconate, 8 mM NaCl, 10 mM HEPES, 0.4 mM EGTA, 2.5 mM QX-314 (N-(2,6-dimethylphenylcarbamoylmethyl) triethylammonium bromide), 2 mM Mg-ATP and 0.25 mM GTP-Tris, pH 7.25. The superfusion solution contained 1 μM tetrodotoxin (Sigma) (to block voltage-gated Na + channels) and 100 μM picrotoxin (to block GABA A receptor-mediated inhibitory synaptic responses). Series resistance was monitored throughout the recordings, and data were discarded if the resistance changed by more than 15%. All data were digitized and collected with Digidata 1322A and pClamp software (version 9.2; Molecular Devices). Signals were filtered at 2 kHz and analyzed with Mini Analysis 6 (Synaptosoft).
Western blot analysis. Mice of each genotype were anesthetized, and the cortex was dissected, quickly frozen at -80 °C, homogenized and sonicated in RIPA buffer with proteinase and phosphatase inhibitors (Thermo Fisher, catalog no. 89900). The protein extract was centrifuged to remove tissue debris, boiled for 15 min, subjected to 10% SDS-PAGE and transferred to a western blot membrane. The membrane was incubated with primary antibodies against PSD-95 (MA1-045, Thermo Fisher; 1:1,000), GFAP (Z0334, Dako; 1:2,000), ATP5Α1 (14748, Abcam; 1:1,000), ATP5h (173006, Abcam; 1:1,000), OXPHOS (ab110413, Abcam; 1:1,000), DLP1 (61112, BD; 1:1,000), OPA1 (80471, Cell Signaling; 1:1,000), ubiquitinylated conjugation (PW8810, Enzolifescience; 1:1,000), p62 (ab91526, Abcam; 1:1,000), β-tubulin (T3592-100UG, Sigma; 1:1,000), GAPDH (10494-1-AP, Proteintech; 1:1,000) and actin (A2228, Sigma-Aldrich; 4967, Cell Signaling; 1:1,000) overnight at 4 °C and then with IRDye secondary antibodies (LI-COR Bioscience) for 1 h at room temperature and analyzed with a LI-COR Odyssey image system. Western blot analysis of human brain samples. Human frontal cortex tissues from 3 control brains and brains of 4 patients with behavioral variant FTD with motor neuron disease (FTD-MND) were lysed in RIPA buffer (Thermo Scientific) containing protease and phosphatase inhibitors. Total protein (30 μg) from each sample was analyzed by western blot (as described above) with primary antibodies against ATP5A1, ATP5H, HSP60, GAPDH and actin. 
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